Your browser doesn't support javascript.
loading
Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination.
Noh, Ji Yun; Cheong, Hee Jin; Kim, Woo Joo; Choi, Ju-Yeon; Lee, Hye Won; Kim, Sung Soon; Kim, Byoungguk; Song, Joon Young.
Afiliação
  • Noh JY; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, South Korea.
  • Cheong HJ; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, South Korea.
  • Kim WJ; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, South Korea.
  • Choi JY; Division of Vaccine Clinical Research Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, South Korea.
  • Lee HW; Division of Vaccine Clinical Research Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, South Korea.
  • Kim SS; Division of Vaccine Clinical Research Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, South Korea.
  • Kim B; Division of Vaccine Clinical Research Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, South Korea. Electronic address: kimbg10@korea.kr.
  • Song JY; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, South Korea. Electronic address: infection@korea.ac.kr.
J Infect ; 85(5): 573-607, 2022 11.
Article em En | MEDLINE | ID: mdl-35921879

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul